Risk-factors for acquisition of extended-spectrum β-lactamase-producing Escherichia coli among hospitalised patients

Clinical Microbiology and Infection

Volumn 12, Issue 3, 2006, Pages 279-284

  Pena C ^a   Gudiol, C ^a   Tubau, F ^a   Saballs, M ^a   Pujol, M ^a   Dominguez, M A ^a   Calatayud, L ^a   Ariza, J ^a   Gudiol, F ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Escherichia coli; Extended spectrum lactamase; Infection; Nosocomial acquisition; Risk factors

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMMUNOSUPPRESSIVE AGENT; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STEROID; TOBRAMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATE; CASE CONTROL STUDY; CLONAL VARIATION; CONTROLLED STUDY; ENTEROBACTER INFECTION; ENZYME SYNTHESIS; ESCHERICHIA COLI; FEMALE; HEMATOLOGIC MALIGNANCY; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; INCIDENCE; INFECTION RISK; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NASOGASTRIC TUBE; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RESPIRATORY TRACT INFECTION; RISK FACTOR; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; SURGICAL INFECTION; URINARY TRACT INFECTION;

BACTERIA (MICROORGANISMS); ENTEROBACTER; ESCHERICHIA COLI;

EID: 33644919433     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2005.01358.x     Document Type: Article

References (22)

1. Sirot J, Chanal C, Petit A, Sirot D, Labia R, Gerbaud G. Klebsiella pneumoniae and other Enterobacteriaceae producing novel plasmid-mediated beta-lactamases markedly active against third-generation cephalosporins: epidemiologic studies. Rev Infect Dis 1988; 10: 850-859.
2. Knothe H, Shah P, Kremery V, Antal M, Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 1983; 11: 315-317.
3. Arlet G, Sanson-Le Pors MJ, Rouveau M et al. Outbreak of nosocomial infections due to Klebsiella pneumoniae producing SHV-4 β-lactamase. Eur J Clin Microbiol Infect Dis 1991; 9: 797-803.
4. Meyer KS, Urban C, Eagan JA, Berger BJ, Rahal JJ. Nosocomial outbreak of Klebsiella pneumoniae resistant to late-generation cephalosporins. Ann Intern Med 1993; 119: 353-358.
5. Peña C, Pujoll M, Ardanuy C et al. Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum β-lactamases. Antimicrob Agents Chemother 1998; 42: 53-58.
6. Bauernfeind A, Horl G. Novel R-factor-borne β-lactamase conferring resistance to cephalosporins. Infection 1987; 15:257-259.
7. Schiappa DA, Hayden MK, Matushek MG et al. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: A case-control and molecular epidemiologic investigation. J Infect Dis 1996; 174: 529-536.
8. Wiener J, Quinn JP, Bradford PA et al. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 1999; 281: 517-523.
9. Lucet JC, Chevres S, Decré D et al. Outbreak of multiply resistant Enterobacteriaceae in an intensive care unit: Epidemiology and risk factors for acquisition. Clin Infect Dis 1996; 22: 430-436.
10. Paterson DL, Ko WCh, Gottberg A et al. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum β-lactamases: Implications for the clinical microbiology laboratory. J Clin Microbiol 2001; 39: 2206-2212.
11. Ho PL, Chan WM, Tsang KWT, Wong SSY, Young K. Bacteremia caused by Escherichia coli producing extended-spectrum beta-lactamase: A case-control study of risk factors and outcomes. Scand J Infect Dis 2002; 34:567-573.
12. Rodriguez-Baños J, Navarro MD, Romero L et al. Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol 2004; 42:1089-1094.
13. Harris AD, Karchmer TB, Carmeli Y, Samore MH. Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: A systematic review. Clin Infect Dis 2001; 32:1055-1061.
14. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16:128-140.
15. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing, 14th informational supplement. Document M100-S12. Wayne, PA: NCCLS, 2004.
16. Legrand P, Fournier G, Buré A et al. Detection of extended broad-spectrum beta-lactamases in Enterobacteriaceae in four French hospitals. Eur J Clin Microbiol Infect Dis 1989; 8:527-529.
17. Coque TM, Oliver A, Pérez-Diaz JC, Baquero F, Cantón R. Genes encoding TEM-4, SHV-2, and CTX-M-10 extended-spectrum β-lactamases are carried by multiple Klebsiella pneumoniae clones in a single hospital (Madrid, 1989-2000). Antimicrob Agents Chemother 2002; 46: 500-510.
18. Sabaté M, Miró E, Navarro F et al. β-Lactamases involved in resistance to broad-spectrum cephalosporins in Escherichia coli and Klebsiella spp. clinical isolates collected between 1994 and 1996, in Barcelona (Spain). J Antimicrob Chemother 2002; 49: 989-997.
19. Paterson DL, Mulazimoglu L, Casellas JM et al. Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum β-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin Infect Dis 2000; 30: 473-478.
20. Lautenbach E, Strom BL, Bilker WB, Patel JB, Edelstein PH, Fishman NO. Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Clin Infect Dis 2001; 33: 1288-1294.
21. Shuttleworth A. The rising incidence of antibiotic-resistant ESBL producing E. coli. Nurs Times 2004; 100: 30-31.
22. Vollaard EJ, Clasener HAL. Colonization resistance. Antimicrob Agents Chemother 1994; 38: 409-414.